Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Roden

Showing results (591-600 of 686) with videos related to

Pageof 69
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2017
Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine ModelRebecca T Emeny, Jens Baumert, Anthony S Zannas, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
Diabetes|October 30, 2014
Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humansTineke van de Weijer, Esther Phielix, Lena Bilet, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
Ebiomedicine|November 12, 2025
Impaired mitochondrial ketone body oxidation in insulin resistant statesElric Zweck, Sarah Piel, Johannes W Schmidt, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Cell Metabolism|October 15, 2022
Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomesRevathi Sekar, Karsten Motzler, Yun Kwon, et al.
Vaccines|May 25, 2024
BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8<sup>+</sup> T Cells in Patients with Type 1 Diabetes in GhanaWilfred Aniagyei, Sumaya Mohayideen, Osei Sarfo-Kantanka, et al.
Diabetes Care|September 22, 2019
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled TrialSabine Kahl, Sofiya Gancheva, Klaus Straßburger, et al.
Pageof 69

Showing results (591-600 of 686) with videos related to

Sort By:
Pageof 69
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2017
Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine ModelRebecca T Emeny, Jens Baumert, Anthony S Zannas, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
Diabetes|October 30, 2014
Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humansTineke van de Weijer, Esther Phielix, Lena Bilet, et al.
Wiener Klinische Wochenschrift|October 17, 2025
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG)Mattias Mandorfer, Georg Semmler, Elmar Aigner, et al.
Ebiomedicine|November 12, 2025
Impaired mitochondrial ketone body oxidation in insulin resistant statesElric Zweck, Sarah Piel, Johannes W Schmidt, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Cell Metabolism|October 15, 2022
Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomesRevathi Sekar, Karsten Motzler, Yun Kwon, et al.
Vaccines|May 25, 2024
BCG Vaccination-Associated Lower HbA1c and Increased CD25 Expression on CD8<sup>+</sup> T Cells in Patients with Type 1 Diabetes in GhanaWilfred Aniagyei, Sumaya Mohayideen, Osei Sarfo-Kantanka, et al.
Diabetes Care|September 22, 2019
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled TrialSabine Kahl, Sofiya Gancheva, Klaus Straßburger, et al.
Pageof 69